Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion.
Yang C, Guo G, Li B, Zheng L, Sun R, Wang X, Deng J, Jia G, Zhou X, Cui L, Guo C, Zhou X, Leung PSC, Gershwin ME, Shang Y, Han Y.
Yang C, et al. Among authors: cui l.
Hepatol Int. 2023 Feb;17(1):237-248. doi: 10.1007/s12072-022-10431-7. Epub 2022 Oct 30.
Hepatol Int. 2023.
PMID: 36309918
Free PMC article.
Clinical Trial.